期刊文献+

阿立哌唑治疗女性精神分裂症的疗效和不良反应评定 被引量:4

The efficacy and the adverse effects of aripiprazole in the treatment of female patients with schizophrenia
下载PDF
导出
摘要 目的了解阿立哌唑治疗女性精神分裂症患者的疗效和不良反应。方法对30例服用阿立哌唑治疗的女性分裂症患者的临床资料进行统计分析,采用BPRS量表、TESS量表和血液检测等评价其疗效和不良反应。结果阿立哌唑治疗女性分裂症前后BPRS总分及各因子分皆明显下降,因子2至因子5治疗前后差异皆有显著统计学意义;对体重影响小,对泌乳素影响小。结论阿立哌唑对女性精神分裂症疗效肯定,对内分泌和体重影响小。 Objective To investigate the efficacy and the adverse effects of Aripiprazole in the treatment of female patients with schizophrenia. Methods Analyzing the clinical materical of 30 female patients with schizophrenia treated with Aripiprazole by BPRS and TESS and the results of blood check. Results The total score and the gene score of BPRS reduced significantly after the treatment. Gene score 2 -5 varied significantly. Aripiprazole has little effects on weight and PRL. Conclusion Aripiprazole is effective for female patients with schizophrenia, the effects on endocrine and weight are small.
作者 周晓琴
出处 《安徽医学》 2009年第5期544-545,共2页 Anhui Medical Journal
关键词 阿立哌唑 女性精神分裂症 疗效 不良反应 Aripiprazole Female patients with schizophrenia Efficacy Adverse effect
  • 相关文献

参考文献4

二级参考文献21

  • 1黄文武,姜德国.抗精神病新药阿立哌唑[J].上海精神医学,2003,15(5):307-308. 被引量:153
  • 2吴仁容,李乐华.新型抗精神病药:阿立哌唑[J].国外医学(精神病学分册),2004,31(3):177-179. 被引量:380
  • 3喻东山.老年精神分裂症的药物治疗[J].临床精神医学杂志,2004,14(5):304-306. 被引量:98
  • 4Kilkuchiet T,et al:J Pharmacol Exp Ther.1995;274(1):329—336.
  • 5Semba J,et al:Neuropharmacology,1995;34(7):785—791.
  • 6Fujikawa M,et al:Pharmacol Biochem Behav.1996;53(4):903—909.
  • 7Alison P,et al:Molecular Brain Research,1998;55:285—292.
  • 8Inoue A。et al:Brain Res Mol Brain Res.1998;55:285—292.
  • 9Shapine DA,et al:Neuropsychopharmacology,2003:1 46(5):214—216.
  • 10Bruce S:Drugs Research and Development,1999;2(1):47—48.

共引文献434

同被引文献18

  • 1童建明,杨正春.几种新型抗精神病药介绍[J].临床精神医学杂志,2005,15(3):182-182. 被引量:147
  • 2李超,胡日柱,钟瑛,胡娟娟.奎硫平与氯氮平对首发女性精神分裂症患者社会功能的影响[J].柳州医学,2010(3):70-72. 被引量:1
  • 3中华医学会精神科分会.中国精神障碍分类与诊断标准[M].济南:山东科学技术出版社,2001.75-90.
  • 4张明园.精神科评定量表手册[M].长沙:湖南科学技术出版社,2003.39.
  • 5Meltzer HY, Li Z, Kanceda Y, et al. Serotonin receptors:their key role in drugs to treat schiz- ophrenia [ J ]. Prog Neuropsy - chopharmacol Biel Psychiatry,2003,27 ( 7 ) : 1159 - 1172.
  • 6Fujikawa M, Nagashima M, Inoue T, et al. Par- tial agonistic effects of OPC - 14597, a poten- tial antipsychotic agent, on yawning behavior in rats [ J ]. Pharmaceol Biochem Behav, 1996,53 (4) :903 -909.
  • 7Deleon A, Patel N C, Crismon M L. Aripi- prazole : a comprehensive review of its pharma- cology, clinielal eflqeacy, and tolerability [ J ]. Clin Ther,2004,26 ( 3 ) :649 - 666.
  • 8Shapiro DA, Renock S, Arrington E, et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology J 1. Neuropsychopharmaeology ,2003,28 ( 8 ) : 1400 - 1411.
  • 9Potkin SG, Saha AR, Kujawa MJ, et al. Aripi- prazole, an antipsychotic with a novel mecha- nism Of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder [ J ]. Arch Gen Psychiatry, 2003,60 (7) :681 -690.
  • 10Marder SR, McQuade RD, Stock E, et al. Aripiprazole in the treatment of schizophrenia : safety and tolerability in short - term, placebo - controlled trials [ J ]. Schizophr Res, 2003, 61(2 -3) :123 -136.

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部